Surgical Pathology for the Oncology Patient in the Age of Standardization: Of Margins, Micrometastasis, and Molecular Markers

Seminars in Radiation Oncology

Volumn 13, Issue 4, 2003, Pages 382-388

  Compton, Carolyn C ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; TUMOR MARKER;

CANCER ADJUVANT THERAPY; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; METASTASIS; MULTIVARIATE ANALYSIS; NOMENCLATURE; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STANDARDIZATION; SURVIVAL RATE; TECHNIQUE; TREATMENT PLANNING; TUMOR CLASSIFICATION;

EID: 0242662722     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(03)00053-5     Document Type: Article

References (33)

1. National Cancer Policy Board, Institute of Medicine and Commission on Life Sciences, National Research Council, in Hewett M, Simone JV (eds): Ensuring Quality Cancer Care. Washington, DC, National Academy Press, 1999
2. National Cancer Policy Board, Institute of Medicine and Commission on Life Sciences, National Research Council, in Hewett M, Simone JV (eds): Ensuring Data Systems to Improve the Quality of Cancer Care. Washington, DC, National Academy Press, 1999
3. Compton CC, Fielding LP, Burgart LJ, et al: Prognostic factors in colorectal cancer: College of American Pathologists Consensus statement 1999. Arch Pathol Lab Med 124:979-994, 2000
4. Compton CC (ed): Practice Protocols for the Examination of Specimens Removed from Patients with Cancer. A Publication of the Cancer Committee of the College of American Pathologists (ed 1). Northfield, IL, College of American Pathologists, 2000
5. Menck HR, Blankenship C, Fremgen A: The national cancer data base and physician network. Top Health Inf Manage 17:45-49, 1997
6. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al: Histopathology reporting in large bowel cancer. J Clin Pathol 34:509-513, 1981
7. Bull AD, Biffin AH, Mella J, et al: Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 50:138-142, 1997
8. Gospodarowicz MK, Henson DE, Hutter RVP et al (ed): Prognostic Factors in Cancer (ed 2). New York, NY, Wiley-Liss, 2001
9. Scott KWM, Grace RH: Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76:1165-1167, 1989
10. Tepper JE, O'Connell MJ, Niedzwiecki D, et al: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157-163, 2001
11. Goldstein NS, Hart J: Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resections. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 111:51-58, 1999
12. Swanson RS, Compton CC, Stewart AK, et al: The prognosis of T3N0 colon cancer is dependent upon the number of lymph nodes examined. Ann Surg Oncol 10:65-71, 2003
13. Wittekind C, Compton CC, Sobin LH: R classification revisited. Cancer 94:2511-2516, 2002
14. Chan K, Boey J, Wong S: A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 9:1319-1327, 1985
15. Quirke P, Durdy P, Dixon MF, et al: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet II:996-999, 1986
16. Quirke P, Scott N: The pathologists role in the assessment of local reccurrence in rectal carcinoma. Surg Oncol Clin N Amer 3:1-17, 1992
17. Adam IJ, Mohamdee MO, Martin IG, et al: Role of the circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707-711, 1994
18. Stacchi L, Nelson H, Sargent DJ, et al: Impact of surgical and pathological variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 19:3895-3902, 2001
19. Nagtegaal ID, van der Worp E, van de Velde CJ, et al: Macroscopic evaluation of rectal cancer resection specimens: Clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734, 2002
20. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, et al: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not millimeter but two millimeters is the limit. Am J Surg Pathol 26:350-357, 2002
21. Birbeck KF, Macklin CP, Tiffin NJ, et al: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rcctal cancer surgery. Ann Surg 235:449-457, 2002
22. Wibe A, Rendedal PR, Svensson E, et al: Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327-334, 2002
23. Ho CM, Ng WF, Lam KH, et al: Radial clearance in resection of hypopharyngeal cancer: an independent prognostic factor. Head Neck 24:181-190, 2002
24. Sagar PM, Johnston D, McMahon MJ, et al: Significance of circumferential margin involvement after oesophagectomy for cancer. Br J Surg 80:1368-1388, 1993
25. Dexter SPL, Sue-Ling H, McMahon MJ, et al: Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 20:667-670, 2001
26. Lüttges J, Vogel I, Menke M, et al: The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal carcinoma of the head of the pancreas. Virchows Archiv 433:237-242, 1998
27. Neoptolemos JP, Stocken DD, Dunn JA, et al: Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758-768, 2001
28. Hall NR, Finan PJ, al-Jaberi T, et al: Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 41:979-983, 1998
29. Petersen VC, Baxter KJ, Love SB, et al: Identification of objective pathologic prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51:65-69, 2002
30. Walker J, Quirke P: Prognosis and response to therapy in colorectal cancer. Eur J Cancer 38:880-886, 2002
31. Wiggers T, van de Velde CJH: The circumferential margin in rectal cancer. Recommendations based on the Dutch Total Mesorectal Excision Study. Eur J Cancer 38:973-976, 2002
32. Nagtegaal ID, van Krieken JHJM: The role of pathologists in the quality control of diagnosis and treatment of rectal cancer - An overview. Eur J Cancer 38:964-972, 2002
33. Hammond MEH, Taube SE: Issues and barriers to development of clinically useful tumor markers: A developmental pathway. Semin Oncol 29:213-221, 2002